Ejaz et al. [103] demonstrated that in mice fed HFD, CRC reduced body weight gain, adiposity, and micro-vessel density in adipose tissue, which coincided with the reduced expression of VEGF and its receptor, VEGFR-2. The gene discussed is VEGFA; the disease is colorectal carcinoma.